Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. - Wikidata - awgldk - TriplyDB

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

http://www.wikidata.org/entity/Q33573423

about

Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.Engineering nanomedicines for improved melanoma therapy: progress and promises.Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects.Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization.Dacarbazine nanoparticle topical delivery system for the treatment of melanoma.Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.

P2860

Q28394719-D0B3720E-9855-4553-A983-552744781CB6 Q33573499-CF7B0B03-0F49-4CB0-B718-3A0F4BF4C0A7 Q33691795-C7B95C40-5589-45E2-AE7D-1C0E16A858B8 Q34280372-41A04DE4-317D-49D6-BA73-5B8CBD82679D Q36032477-2157E5B1-85F1-48AA-BBB4-588296370FB3 Q36936646-D05BE3BD-BF69-47DE-B70B-5838CCCEDA8B Q37905839-0019B353-9D24-4BCB-BB07-FDA5182C110C Q41864793-A2543221-9ACC-411B-82EF-D7621728E62F Q46218236-C94D8BFB-5859-486C-8AD0-84FA06EFE0AE Q47109616-C2F3B953-ED55-415A-8B92-97F754692C0D Q53174701-9747BE6F-9AEC-4C1C-9C46-1DC0A02446B2

P2860

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

http://www.wikidata.org/entity/Q33573423

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@ast

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@en

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@nl

type

label

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@ast

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@en

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@nl

prefLabel

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@ast

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@en

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@nl

P1433

Q33573423-8CAAABCE-392F-4B0E-B77F-DA7812E7DD3A

P1476

Q33573423-0BDFAAAD-93AC-4DE6-8036-24135414A35D

P2093

Q33573423-35E37F96-7168-4C3C-B978-4A1AE1AC8C3B

Q33573423-9995D26A-604F-4639-895F-E9C26D8DE717

P2860

Q33573423-06267B2C-1917-474E-8E84-4DC88A104138

Q33573423-096AFA71-B504-4301-B2E0-177C5F877DD4

Q33573423-190BE521-307E-4348-A678-FCF8D07DEAB5

Q33573423-256FDD67-43A2-4591-9D9F-3350F0A9E978

Q33573423-385D9829-AE7A-4D73-86DF-735CDADAEDA8

Q33573423-3B930D1D-39BD-4603-BCF6-AFF44A979996

Q33573423-400AB90C-E46B-49AD-A229-ED7E38164F7C

Q33573423-4266FD7E-782B-4953-B4D0-FD54398139E4

Q33573423-43C3D371-7213-41E0-8168-A9E9EF8AFDF1

Q33573423-542DD028-C5DB-41A8-A88C-5BFC5C551F0E

P2888

Q33573423-B154A019-12AA-4906-93F7-BDDE3B02A0A6

P304

Q33573423-008F5181-D0FC-4096-990A-B1A5199A527F

P31

Q33573423-7FFFEC64-E1B8-4355-98CE-2EED26E29974

P356

Q33573423-EE3AE84E-30A5-4F83-A324-23A89213AF58

P407

Q33573423-B2D10F40-8CFA-4DCE-81FD-011B97B38E29

P433

Q33573423-955AE21B-A404-4339-AC7A-36F83CF25BA0

P478

Q33573423-CC2DD251-4975-4B75-AEDB-74BDAA7C84E3

P50

Q33573423-B035A9A4-F7D6-4037-A019-01CBFFE76083

P577

Q33573423-D56103D7-3807-4ECA-B90F-5442854E72E8

P5875

Q33573423-4AEE03C2-F4D2-449F-A29D-88520DBA8088

P6179

Q33573423-B06844C0-F6E9-45A1-A2F7-AE9A043A777E

P698

Q33573423-5E55BDB7-29A9-414A-8B56-96DF362A5A09

P932

Q33573423-EDC52E83-6B6A-4BA7-923B-E27E70EB0AD2

P356

S12249-009-9293-3

P1433

AAPS PharmSciTech

P1476

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

@en

P2093

Bi-Botti C Youan

http://www.w3.org/2001/XMLSchema#string

Di Bei

http://www.w3.org/2001/XMLSchema#string

P2860

Characterisation of drug release from cubosomes using the pressure ultrafiltration method.

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).

Cubic phase gels as drug delivery systems.

Long-circulating and target-specific nanoparticles: theory to practice.

Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability.

Systemic chemotherapy in the treatment of malignant melanoma.

Cubosomes: an overview.

Statistical designs and response surface techniques for the optimization of chromatographic systems.

5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

P2888

s12249-009-9293-3

P304

1032-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-009-9293-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jacob Marszalek

P577

2009-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26731459

http://www.w3.org/2001/XMLSchema#string

P6179

1021767279

http://www.w3.org/2001/XMLSchema#string

P698

19669896

http://www.w3.org/2001/XMLSchema#string

P932

2802140

http://www.w3.org/2001/XMLSchema#string